Iambic Therapeutics, Inc. ·
IAM 8-K 2026-11-16
Iambic Therapeutics, Inc. (IAM) 8-K dated 2026-11-16 — accession 0001193125-26-462184.
Iambic Therapeutics, Inc. (IAM) common stock.
Iambic Therapeutics, Inc. filed a 8-K on 2026-11-16. Accession 0001193125-26-462184.
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for IAM is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The IAM SEC hub lists recent forms. The stock page is the research view.